Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancers|December 24, 2021
Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival OutcomesHira Shaikh, Julie E McGrath, Brittany Hughes, et al.
Blood Cancer Journal|March 11, 2025
A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myelomaRachel Dileo, Prerna Mewawalla, Kalaivani Babu, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal ImpairmentAlma Habib, Nausheen Ahmed, Abdullah Mohammad Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid CancerMartina Chirra, Andrew Elliott, Hira Shaikh, et al.
Blood Advances|January 28, 2026
Clinical Features of Systemic Amyloidosis: A Scoping ReviewJoselle Cook, Hira Shaikh, Muayad Azzam, et al.
Cancers|November 13, 2025
Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed IntervalsJordan Snyder, Shebli Atrash, Barry Paul, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2025
Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 TrialIshita Kamboj, Alma Habib, Darryl Chang, et al.
Transplantation and Cellular Therapy|December 27, 2023
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World ExperienceDanai Dima, James A Davis, Nausheen Ahmed, et al.
Cancers|October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma PatientsKate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Cancers|March 14, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC GroupMaha Hameed, Alma Habib, Abdullah Mohammad Khan, et al.
Pageof 4